Recent changes
Jump to navigation
Jump to search
Track the most recent changes to the wiki on this page.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
19 April 2024
| m 12:34 | Mantle cell lymphoma diffhist 0 Jwarner talk contribs →Lenalidomide monotherapy {{#subobject:b5de78|Regimen=1}} | ||||
|
|
m 12:32 | Head and neck cancer 3 changes history +1,820 [Jwarner (3×)] | |||
| m |
|
12:32 (cur | prev) +594 Jwarner talk contribs →Methotrexate monotherapy {{#subobject:0e90b2|Regimen=1}} | |||
| m |
|
12:25 (cur | prev) +293 Jwarner talk contribs →Cetuximab monotherapy {{#subobject:4b973b|Regimen=1}} | |||
| m |
|
12:24 (cur | prev) +933 Jwarner talk contribs →Docetaxel monotherapy {{#subobject:623c3f|Regimen=1}} | |||
| m 12:30 | Glioblastoma diffhist +280 Jwarner talk contribs →Carmustine & RT {{#subobject:ee9fbd|Regimen=1}} | ||||
| m 12:15 | B-cell acute lymphoblastic leukemia, Ph-positive diffhist -36 Jwarner talk contribs →Dasatinib, Vincristine, Prednisone {{#subobject:71a41c|Regimen=1}} | ||||
|
|
m 12:11 | Acute myeloid leukemia, FLT3-positive 3 changes history +9 [Jwarner (3×)] | |||
| m |
|
12:11 (cur | prev) +3 Jwarner talk contribs →Regimen {{#subobject:bd7f87|Variant=1}} | |||
| m |
|
12:11 (cur | prev) +3 Jwarner talk contribs →FLAG-Ida {{#subobject:d8c75b|Regimen=1}} | |||
| m |
|
12:10 (cur | prev) +3 Jwarner talk contribs →Regimen {{#subobject:c9nqa0|Variant=1}} | |||
| m 11:17 | Chronic lymphocytic leukemia diffhist +337 Jwarner talk contribs →Ofatumumab monotherapy {{#subobject:75bd7e|Regimen=1}} | ||||
|
|
m 11:12 | Breast cancer, triple negative 2 changes history -5 [Jwarner (2×)] | |||
| m |
|
11:12 (cur | prev) -4 Jwarner talk contribs | |||
| m |
|
11:11 (cur | prev) -1 Jwarner talk contribs →Paclitaxel & Pembrolizumab {{#subobject:2g8gua|Regimen=1}} | |||
| m 11:07 | Breast cancer, BRCA-mutated diffhist +29 Jwarner talk contribs →Regimen variant #2, 300 mg twice per day {{#subobject:3b0774|Variant=1}} | ||||
|
|
m 11:00 | Colorectal cancer, MSI-H or dMMR 3 changes history -55 [Jwarner (3×)] | |||
| m |
|
11:00 (cur | prev) +8 Jwarner talk contribs →Regimen {{#subobject:3af038|Variant=1}} | |||
| m |
|
11:00 (cur | prev) +2 Jwarner talk contribs →Regimen {{#subobject:3af038|Variant=1}} | |||
| m |
|
10:59 (cur | prev) -65 Jwarner talk contribs →Pembrolizumab monotherapy {{#subobject:5aa59d|Regimen=1}} | |||
|
|
m 00:36 | Esophageal squamous cell carcinoma 3 changes history +27 [Jwarner (3×)] | |||
| m |
|
00:36 (cur | prev) -1 Jwarner talk contribs →Nivolumab monotherapy {{#subobject:10ee99|Regimen=1}} | |||
| m |
|
00:35 (cur | prev) -1 Jwarner talk contribs →Regimen {{#subobject:d1dde0|Variant=1}} | |||
| m |
|
00:35 (cur | prev) +29 Jwarner talk contribs →Camrelizumab monotherapy {{#subobject:c701c3|Regimen=1}} | |||
| m 00:29 | Non-small cell lung cancer, nonsquamous diffhist -39 Jwarner talk contribs →Regimen variant #2, 5/500 x 4, then maintenance pem x 2y {{#subobject:1mwjm3|Variant=1}} | ||||
|
|
00:19 | Ovarian cancer, HRD-positive 6 changes history +7,214 [Jwarner (6×)] | |||
|
|
00:19 (cur | prev) +1,816 Jwarner talk contribs →Paclitaxel monotherapy {{#subobject:f47paa|Regimen=1}} | ||||
|
|
00:17 (cur | prev) +1,791 Jwarner talk contribs →Paclitaxel monotherapy {{#subobject:f47paa|Regimen=1}} | ||||
|
|
00:16 (cur | prev) +1,794 Jwarner talk contribs →Olaparib monotherapy {{#subobject:f47yha|Regimen=1}} | ||||
| m |
|
00:14 (cur | prev) +686 Jwarner talk contribs | |||
| m |
|
00:14 (cur | prev) -686 Jwarner talk contribs | |||
|
|
00:13 (cur | prev) +1,813 Jwarner talk contribs →Olaparib monotherapy {{#subobject:f47yha|Regimen=1}} | ||||
18 April 2024
| m 23:47 | Gastric cancer, HER2-positive diffhist -2 Jwarner talk contribs →Regimen {{#subobject:577cd6|Variant=1}} | ||||
|
|
m 23:44 | Peripheral T-cell lymphoma 2 changes history +22 [Jwarner (2×)] | |||
| m |
|
23:44 (cur | prev) +3 Jwarner talk contribs →References | |||
| m |
|
23:44 (cur | prev) +19 Jwarner talk contribs →Gemcitabine monotherapy {{#subobject:7dbc1c|Regimen=1}} | |||
| m 23:43 | Peripheral T-cell lymphoma - historical diffhist +2 Jwarner talk contribs →References | ||||
| m 23:39 | Clear cell renal cell carcinoma diffhist +807 Jwarner talk contribs | ||||
| m 23:36 | Clear cell renal cell carcinoma - null regimens diffhist +730 Jwarner talk contribs →Placebo | ||||
| m 20:40 | Non-small cell lung cancer, ALK-positive diffhist +4 Jwarner talk contribs →Regimen {{#subobject:9cef11|Variant=1}} | ||||
| m 20:39 | Alectinib (Alecensa) diffhist +255 Jwarner talk contribs →History of changes in FDA indication | ||||
16 April 2024
| m 17:14 | ASCO guidelines diffhist -1 Warner-admin talk contribs Text replacement - "old-prod.asco.org" to "society.asco.org" | ||||
| m 17:14 | Drug shortages diffhist -1 Jwarner talk contribs →Links | ||||
15 April 2024
| 20:16 | Classical Hodgkin lymphoma, pediatric diffhist 0 Warner-admin talk contribs | ||||
| 20:07 | Hepatoblastoma diffhist -1 Warner-admin talk contribs | ||||
|
|
20:04 | Rhabdomyosarcoma, pediatric 3 changes history +5 [Warner-admin (3×)] | |||
|
|
20:04 (cur | prev) -29 Warner-admin talk contribs →Low Risk | ||||
|
|
20:03 (cur | prev) +17 Warner-admin talk contribs →Intermediate Risk | ||||
|
|
19:57 (cur | prev) +17 Warner-admin talk contribs →High Risk | ||||
| 20:01 | Gestational trophoblastic neoplasia diffhist -16 Warner-admin talk contribs | ||||
| 19:59 | Rhabdomyosarcoma, pediatric - historical diffhist 0 Warner-admin talk contribs | ||||
| 19:57 | Neuroblastoma - historical diffhist +18 Warner-admin talk contribs →High Risk | ||||
| m 19:20 | Multiple myeloma, consolidation and maintenance diffhist -1 Jwarner talk contribs →Thalidomide & Prednisolone (TP) {{#subobject:1agdc9|Regimen=1}} | ||||
| m 18:42 | Follicular lymphoma - historical diffhist +255 Jwarner talk contribs →131Iodine-Tositumomab monotherapy {{#subobject:f69726|Regimen=1}} | ||||